TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/28/23 12:29 | 6/6/22 | URGN | Urogen Pharma Ltd. | L3 | Health | Drug | Pharmaceutical Preparations | Nussbaum Ran | NJ | D | M.ad | 5 | 5.00 | 0 | 1 | 0 | 1,435 | I | |||||||||||||||
2/28/23 12:23 | 10/21/22 | URGN | Urogen Pharma Ltd. | L3 | Health | Drug | Pharmaceutical Preparations | Nussbaum Ran | NJ | D | M.ad | 285 | 5.94 | 0 | 48 | 3 | 1,485 | I | |||||||||||||||
2/28/23 12:21 | 6/16/22 | URGN | Urogen Pharma Ltd. | L3 | Health | Drug | Pharmaceutical Preparations | Nussbaum Ran | NJ | D | M.d | 11 | 5.00 | 0 | 2 | 0 | 1,437 | I | |||||||||||||||
10/25/22 16:57 | 10/21/22 | URGN | Urogen Pharma Ltd. | L3 | Health | Drug | Pharmaceutical Preparations | Nussbaum Ran | NJ | D | M.d | 285 | 5.94 | 0 | 48 | 3 | 1,482 | I | |||||||||||||||
8/25/22 15:25 | 6/6/22 | URGN | Urogen Pharma Ltd. | L3 | Health | Drug | Pharmaceutical Preparations | Nussbaum Ran | NJ | D | M.d | 5 | 5.00 | 0 | 1 | 0 | 1,434 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |